Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report: February 6, 2007
(Date
of
earliest event reported)
GENOMIC
HEALTH, INC.
(Exact
name of registrant as specified in its charter)
| |
Delaware
|
|
000-51541
|
|
77-0552594
|
|
| |
(State
or Other Jurisdiction of
Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification
Number)
|
|
| |
301
Penobscot Drive
Redwood
City, California
|
|
94063
|
|
| |
(Address
of principal executive offices)
|
|
(Zip
Code)
|
|
(650)
556-3900
(Registrant’s
telephone number,
including
area code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
ITEM
2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On
February 6, 2007, Genomic Health, Inc. issued
a
press release announcing financial results for its fourth fiscal quarter ended
December 31, 2006 and for its fiscal year ended December 31, 2006. The full
text
of the press release is furnished as Exhibit 99.1.
ITEM
8.01 OTHER EVENTS.
The
Company’s 2007 Annual Meeting of
Stockholders will
be
held on May 17, 2007 at such place and time as will be set forth in the
Company’s proxy statement relating to that meeting. A stockholder proposal not
included in the proxy statement for the Company’s 2007 Annual Meeting of
Stockholders will be ineligible for presentation at the meeting unless the
stockholder gives timely notice of the proposal in writing to the Secretary
of
the Company at the principal executive offices of the Company and otherwise
complies with the provisions of the Company’s Bylaws. For the 2007 Annual
Meeting of Stockholders, to be timely, the Company’s Bylaws provide that the
Secretary of the Company must have received the stockholder’s notice not earlier
than ninety (90) days nor more than one hundred twenty (120) days in
advance of the date the Company’s proxy statement was released to the
stockholders in connection with the previous year’s annual meeting of
stockholders. For the Company’s 2007 Annual Meeting of Stockholders,
stockholders must have submitted written notice to the Secretary in accordance
with the foregoing Bylaw provisions not earlier than December 29, 2006 nor
later
than January 28, 2007.
ITEM 9.01 FINANCIAL
STATEMENTS AND EXHIBITS.
| |
(d) |
Exhibits |
| |
|
|
| |
|
99.1 Press
release issued by Genomic Health, Inc. dated February 6,
2007. |
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated:
February 6, 2007
| |
|
|
| |
GENOMIC
HEALTH,
INC. |
|
|
|
| |
By: |
/s/
G. Bradley
Cole
|
| |
G.
Bradley Cole
|
| |
Executive
Vice
President and
Chief
Financial Officer
|
| |
(title)
|